Can you tell me how you have arrived at the $5B cash by next year as I'm not anywhere close to that.
My numbers suggest by mid next year the company will have closer to $2-2.4B in cash as they still have a large tax bill to pay, they have large capex spend underway and the Spodumene price has dropped substantially.
I also have a forecast PE ratio of around 11.5 for 2023/34 compared to your 4.7 and the average forecast from the 12 brokers on morning star is a PE of 12.9 for 2023/24 and 12.6 for 2024/45
I do agree though that the company still has a strong balance sheet and is fair value at current prices.
Good News & Bad News, page-36173
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.14 |
Change
-0.030(0.72%) |
Mkt cap ! $12.46B | |||
| Open | High | Low | Value | Volume |
| $4.19 | $4.22 | $4.11 | $64.82M | 15.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96377 | $4.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.14 | 150292 | 11 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.13 |
Change
-0.030 ( 1.08 %) |
||||
| Open | High | Low | Volume | ||
| $4.18 | $4.22 | $4.11 | 5188310 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| PLS (ASX) Chart |